FindTrial
Sign In

Armolipid Plus

DIETARY_SUPPLEMENT4 trials

Sponsors

Rottapharm, Rottapharm Spain, Federico II University

Conditions

Cardiovascular Risk FactorsElevated TriglyceridesHyperlipidemiaInsulin-resistanceLeft Ventricular HypertrophyLow-density-lipoprotein-typeMetabolic Syndrome

Phase 2

Combined Effects of Bioactive Compounds in Lipid Profile
CompletedNCT01562080
Rottapharm SpainElevated Triglycerides, Hyperlipidemia, Low-density-lipoprotein-type
Start: 2012-01-31End: 2012-10-31Updated: 2013-02-28

Unknown Phase

Armolipid Plus and Metabolic Syndrome
CompletedNCT01087632
RottapharmMetabolic Syndrome
Start: 2009-09-30End: 2010-07-31Updated: 2010-09-02
Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome
CompletedNCT02295176
RottapharmInsulin-resistance, Left Ventricular Hypertrophy, Metabolic Syndrome
Start: 2013-04-30End: 2015-07-31Updated: 2015-10-27
Effects of LopiGLIK® on Cardiovascular Risk
CompletedNCT02898805
Federico II UniversityCardiovascular Risk Factors
Start: 2016-01-31End: 2018-12-01Updated: 2019-07-30

Related Papers

Dual modulation of lipid and glucose metabolism by a nutraceutical combination in patients at cardiometabolic risk: results from a multicenter randomized controlled trial.
2025-10-03
A nutraceutical combination reduces left ventricular mass in subjects with metabolic syndrome and left ventricular hypertrophy: A multicenter, randomized, double-blind, placebo-controlled trial.
2019-07-1915 citations
A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK<sup>®</sup>) lowering cardiovascular disease risk
ClinicoEconomics and Outcomes Research2018-10-013 citations
Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.
2016-03-2520 citations
Effects of Poly-Bioactive Compounds on Lipid Profile and Body Weight in a Moderately Hypercholesterolemic Population with Low Cardiovascular Disease Risk: A Multicenter Randomized Trial
PLoS ONE2014-08-0155 citations